JY

Jaiwant Yeshwant Sardesai

Director Director DIN 01142324
DIN 01142324 First appointment Jun 1999 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Jun 1999
Shareholding value •••• Premium profile

About Jaiwant Yeshwant Sardesai

Data last updated:

Jaiwant Yeshwant Sardesai was a Director at Dci Pharmaceuticals Private Limited (1999–2007) and Director at Medizest Pharmaceuticals Private Limited (2007–2010). The companies operate in Healthcare and Pharma.

DIN 01142324
Primary Designation Director
Industry Healthcare
First Appointment 07 Jun 1999

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Dci Pharmaceuticals Private Limited U24231GA1975PTC000251
Director07 Jun 19991975₹21.53 Cr (FY 2024)Active
Director01 Dec 20071987₹20.59 Cr (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Dci Pharmaceuticals Private Limited
Medizest Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Jaiwant Yeshwant Sardesai

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jaiwant Yeshwant Sardesai

Jaiwant Yeshwant Sardesai was first appointed on 07 Jun 1999 as Director at Dci Pharmaceuticals Private Limited. The most recent appointment on record is 01 Dec 2007 at Medizest Pharmaceuticals Private Limited.

Jaiwant Yeshwant Sardesai held 2 earlier board appointments: Dci Pharmaceuticals Private Limited (Director, 07 Jun 1999 to 27 Jun 2007); Medizest Pharmaceuticals Private Limited (Director, 01 Dec 2007 to 26 Feb 2010).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available